Upgrade to SI Premium - Free Trial

Piper Sandler on Medtronic, Inc. (MDT): 'We Remain Cautious on the Outlook'

November 14, 2025 7:53 AM
Piper Sandler analyst Matt O'Brien reiterated a Neutral rating and $90.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles